Form 4: Regulus Therapeutics Director Jason Nunn Acquires 30,000 Stock Options

Director Jason Nunn acquired 30,000 stock options in Regulus Therapeutics Inc. on May 16, 2024, as part of the company's Non-Employee Director's Compensation policy.

Summary

• On May 16, 2024, Jason Nunn, a director of Regulus Therapeutics Inc., acquired 30,000 stock options.
• The exercise price of these options is $2.01.
• These options were granted pursuant to the company's Non-Employee Director's Compensation policy.
• The options vest ratably over twelve months from the grant date, or until the next annual stockholder meeting, whichever comes first, contingent upon continuous service.
• The options expire on May 15, 2034.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options is a routine part of director compensation and aligns interests with shareholders. There are no red flags or negative implications.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the options.

Industry Context

This is a standard practice for compensating non-employee directors in publicly traded companies, aligning their interests with those of shareholders through equity ownership.

Comparison to Industry Standards

• Granting stock options to directors is a common practice among publicly traded companies to align their interests with shareholders.
• The vesting schedule of twelve months is fairly standard, similar to companies like Amgen and Biogen, which often use similar vesting periods for equity grants to directors.
• The exercise price of $2.01 is based on the market value of the stock at the time of the grant, which is typical.
• The ten-year expiration date is also a common feature in stock option agreements, providing a long-term incentive for directors.

Stakeholder Impact

• The granting of stock options to a director can positively impact shareholders by aligning the director's interests with the company's long-term success.

Key Dates